Fabry Disesase clinical trials at UCLA

1 in progress, 0 open to eligible people

HM15421/GC1134A in Patients with Fabry Disease
Sorry, not yet accepting patients
This Phase 1/2 first-in-human (FIH) study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of HM15421 in patients with FD.
Los Angeles, California and other locations

Last updated: February 27, 2025